4.8 Article

SIDT2 Transports Extracellular dsRNA into the Cytoplasm for Innate Immune Recognition

Journal

IMMUNITY
Volume 47, Issue 3, Pages 498-+

Publisher

CELL PRESS
DOI: 10.1016/j.immuni.2017.08.007

Keywords

-

Categories

Funding

  1. Australian NHMRC [520574, 1064591, 1123319, 1006592, 1045549, 1065626]
  2. Royal Australasian College of Physicians
  3. Menzies Foundation
  4. CASS Foundation [SM13-4846, SM14-5566]
  5. Reid Family Trust
  6. Sylvia & Charles Viertel Senior Medical Research Fellowship
  7. Victorian State Government
  8. Independent Research Institutes Infrastructure Support Scheme (NHMRC)
  9. GlaxoSmithKline
  10. US NIH [1R01GM089795, U19CA179513]
  11. National Health and Medical Research Council of Australia [1123319, 1064591, 1065626] Funding Source: NHMRC

Ask authors/readers for more resources

Double-stranded RNA (dsRNA) is a common by-product of viral infections and acts as a potent trigger of antiviral immunity. In the nematode C. elegans, sid-1 encodes a dsRNA transporter that is highly conserved throughout animal evolution, but the physiological role of SID-1 and its orthologs remains unclear. Here, we show that the mammalian SID-1 ortholog, SIDT2, is required to transport internalized extracellular dsRNA from endocytic compartments into the cytoplasm for immune activation. Sidt2-deficient mice exposed to extracellular dsRNA, encephalomyocarditis virus (EMCV), and herpes simplex virus 1 (HSV-1) show impaired production of antiviral cytokines and-in the case of EMCV and HSV-1-reduced survival. Thus, SIDT2 has retained the dsRNA transport activity of its C. elegans ortholog, and this transport is important for antiviral immunity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available